Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis DOI Creative Commons
Saeed Khorramnia, Zia Navidi, Amirhossein Orandi

et al.

Deleted Journal, Journal Year: 2024, Volume and Issue: 38(2), P. 136 - 144

Published: June 21, 2024

Tixagevimab/cilgavimab (Tix/Cil) shows promise as a prophylactic treatment against coronavirus disease 2019 (COVID-19) in solid organ transplant recipients (SOTRs). This study was performed to assess the effectiveness of Tix/Cil for preexposure prophylaxis COVID-19 this population.

Language: Английский

Situación actual de la inmunización pasiva frente al COVID en los pacientes respiratorios DOI Creative Commons
Víctor Manuel Mora Cuesta, Beatríz Arana Gómez,

Raquel Pérez Rojo

et al.

Open Respiratory Archives, Journal Year: 2025, Volume and Issue: 7(2), P. 100398 - 100398

Published: Jan. 18, 2025

Citations

0
Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis DOI Creative Commons
Saeed Khorramnia, Zia Navidi, Amirhossein Orandi

et al.

Deleted Journal, Journal Year: 2024, Volume and Issue: 38(2), P. 136 - 144

Published: June 21, 2024

Tixagevimab/cilgavimab (Tix/Cil) shows promise as a prophylactic treatment against coronavirus disease 2019 (COVID-19) in solid organ transplant recipients (SOTRs). This study was performed to assess the effectiveness of Tix/Cil for preexposure prophylaxis COVID-19 this population.

Language: Английский

Citations

2